AlphaFold predicted structure
CDT1 · Q9H211

Mean pLDDT
73.4/ 100
Confident
546 residues
Confidence breakdown
- Very high(≥ 90)34%
- Confident(70–90)28%
- Low(50–70)13%
- Very low(< 50)26%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
chromatin licensing and DNA replication factor 1
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalDeafness and congenital structural abnormalities
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIUGR and IGF abnormalities
BIALLELIC, autosomal or pseudoautosomalSevere microcephaly
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalMonogenic short stature
BIALLELIC, autosomal or pseudoautosomalEar-patella-short stature syndrome
neurodegenerative disease
Meier-Gorlin syndrome
microcephalic primordial dwarfism
hereditary disease
actinic keratosis
hepatocellular carcinoma
cancer
lung carcinoma
lung cancer
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
DNA replication factor Cdt1
Required for both DNA replication and mitosis (PubMed:11125146, PubMed:14993212, PubMed:21856198, PubMed:22581055, PubMed:26842564). DNA replication licensing factor, required for pre-replication complex assembly. Cooperates with CDC6 and the origin recognition complex (ORC) during G1 phase of the cell cycle to promote the loading of the mini-chromosome maintenance (MCM) complex onto DNA to generate pre-replication complexes (pre-RC) (PubMed:14672932). Required also for mitosis by promoting stable kinetochore-microtubule attachments (PubMed:22581055). Potential oncogene (By similarity)
CDT1 · Q9H211

Mean pLDDT
73.4/ 100
Confident
546 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0